nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—obesity—type 2 diabetes mellitus	0.432	1	CtDrD
Benzphetamine—ADRA2A—type 2 diabetes mellitus	0.122	0.685	CbGaD
Benzphetamine—CYP3A4—type 2 diabetes mellitus	0.0563	0.315	CbGaD
Benzphetamine—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.0497	0.303	CrCrCtD
Benzphetamine—Dextroamphetamine—Nateglinide—type 2 diabetes mellitus	0.0385	0.235	CrCrCtD
Benzphetamine—Amphetamine—Nateglinide—type 2 diabetes mellitus	0.0385	0.235	CrCrCtD
Benzphetamine—Methamphetamine—Nateglinide—type 2 diabetes mellitus	0.0374	0.228	CrCrCtD
Benzphetamine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0243	0.196	CbGbCtD
Benzphetamine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0233	0.188	CbGbCtD
Benzphetamine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0116	0.0938	CbGbCtD
Benzphetamine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0103	0.0836	CbGbCtD
Benzphetamine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00946	0.0764	CbGbCtD
Benzphetamine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00827	0.0668	CbGbCtD
Benzphetamine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00748	0.0604	CbGbCtD
Benzphetamine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00567	0.0458	CbGbCtD
Benzphetamine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00544	0.0439	CbGbCtD
Benzphetamine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00544	0.0439	CbGbCtD
Benzphetamine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00514	0.0415	CbGbCtD
Benzphetamine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00383	0.0309	CbGbCtD
Benzphetamine—Cardiac valve disease—Bromocriptine—type 2 diabetes mellitus	0.00352	0.0621	CcSEcCtD
Benzphetamine—CYP3A4—Losartan—type 2 diabetes mellitus	0.0035	0.0283	CbGbCtD
Benzphetamine—Psychotic episode—Bromocriptine—type 2 diabetes mellitus	0.00333	0.0588	CcSEcCtD
Benzphetamine—Digestion impaired—Tolbutamide—type 2 diabetes mellitus	0.0017	0.03	CcSEcCtD
Benzphetamine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00163	0.182	CbGeAlD
Benzphetamine—Digestion impaired—Tolazamide—type 2 diabetes mellitus	0.00155	0.0273	CcSEcCtD
Benzphetamine—Digestion impaired—Chlorpropamide—type 2 diabetes mellitus	0.00155	0.0273	CcSEcCtD
Benzphetamine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.0011	0.122	CbGeAlD
Benzphetamine—Digestion impaired—Glipizide—type 2 diabetes mellitus	0.00103	0.0181	CcSEcCtD
Benzphetamine—Digestion impaired—Glyburide—type 2 diabetes mellitus	0.00079	0.0139	CcSEcCtD
Benzphetamine—SLC6A3—nerve—type 2 diabetes mellitus	0.000765	0.0853	CbGeAlD
Benzphetamine—Digestion impaired—Gliclazide—type 2 diabetes mellitus	0.000709	0.0125	CcSEcCtD
Benzphetamine—SLC6A2—nerve—type 2 diabetes mellitus	0.000617	0.0688	CbGeAlD
Benzphetamine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.00056	0.0624	CbGeAlD
Benzphetamine—POR—islet of Langerhans—type 2 diabetes mellitus	0.000514	0.0573	CbGeAlD
Benzphetamine—Sweating—Nateglinide—type 2 diabetes mellitus	0.000514	0.00907	CcSEcCtD
Benzphetamine—Digestion impaired—Ramipril—type 2 diabetes mellitus	0.000452	0.00797	CcSEcCtD
Benzphetamine—POR—nephron tubule—type 2 diabetes mellitus	0.000414	0.0462	CbGeAlD
Benzphetamine—Psychotic disorder—Bromocriptine—type 2 diabetes mellitus	0.000409	0.00723	CcSEcCtD
Benzphetamine—Tremor—Nateglinide—type 2 diabetes mellitus	0.000392	0.00692	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Miglitol—type 2 diabetes mellitus	0.000389	0.00687	CcSEcCtD
Benzphetamine—Palpitations—Nateglinide—type 2 diabetes mellitus	0.00037	0.00653	CcSEcCtD
Benzphetamine—Sweating—Glipizide—type 2 diabetes mellitus	0.000368	0.00649	CcSEcCtD
Benzphetamine—Dyspepsia—Tolbutamide—type 2 diabetes mellitus	0.000357	0.0063	CcSEcCtD
Benzphetamine—POR—cortex of kidney—type 2 diabetes mellitus	0.000354	0.0395	CbGeAlD
Benzphetamine—Sweating—Pioglitazone—type 2 diabetes mellitus	0.000352	0.00622	CcSEcCtD
Benzphetamine—Anorexia—Chlorpropamide—type 2 diabetes mellitus	0.000352	0.00621	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Tolbutamide—type 2 diabetes mellitus	0.00035	0.00618	CcSEcCtD
Benzphetamine—Sweating—Glimepiride—type 2 diabetes mellitus	0.000343	0.00606	CcSEcCtD
Benzphetamine—Hyperhidrosis—Nateglinide—type 2 diabetes mellitus	0.00033	0.00583	CcSEcCtD
Benzphetamine—POR—adipose tissue—type 2 diabetes mellitus	0.000328	0.0366	CbGeAlD
Benzphetamine—Dyspepsia—Chlorpropamide—type 2 diabetes mellitus	0.000325	0.00573	CcSEcCtD
Benzphetamine—Dyspepsia—Tolazamide—type 2 diabetes mellitus	0.000325	0.00573	CcSEcCtD
Benzphetamine—Urticaria—Tolbutamide—type 2 diabetes mellitus	0.000322	0.00569	CcSEcCtD
Benzphetamine—Decreased appetite—Chlorpropamide—type 2 diabetes mellitus	0.000321	0.00566	CcSEcCtD
Benzphetamine—Palpitations—Repaglinide—type 2 diabetes mellitus	0.00032	0.00565	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Tolazamide—type 2 diabetes mellitus	0.000318	0.00562	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Chlorpropamide—type 2 diabetes mellitus	0.000318	0.00562	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Linagliptin—type 2 diabetes mellitus	0.000315	0.00556	CcSEcCtD
Benzphetamine—SLC18A2—adipose tissue—type 2 diabetes mellitus	0.000313	0.0348	CbGeAlD
Benzphetamine—Dyspepsia—Acarbose—type 2 diabetes mellitus	0.000312	0.00551	CcSEcCtD
Benzphetamine—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.000308	0.00545	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Acarbose—type 2 diabetes mellitus	0.000306	0.0054	CcSEcCtD
Benzphetamine—Dyspepsia—Nateglinide—type 2 diabetes mellitus	0.000301	0.00531	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Nateglinide—type 2 diabetes mellitus	0.000295	0.00521	CcSEcCtD
Benzphetamine—Urticaria—Chlorpropamide—type 2 diabetes mellitus	0.000293	0.00517	CcSEcCtD
Benzphetamine—Urticaria—Tolazamide—type 2 diabetes mellitus	0.000293	0.00517	CcSEcCtD
Benzphetamine—Urticaria—Linagliptin—type 2 diabetes mellitus	0.00029	0.00512	CcSEcCtD
Benzphetamine—Amphetamine—CARTPT—type 2 diabetes mellitus	0.000288	0.15	CrCbGaD
Benzphetamine—Urticaria—Acarbose—type 2 diabetes mellitus	0.000281	0.00497	CcSEcCtD
Benzphetamine—Tremor—Glipizide—type 2 diabetes mellitus	0.000281	0.00496	CcSEcCtD
Benzphetamine—Urticaria—Nateglinide—type 2 diabetes mellitus	0.000271	0.00479	CcSEcCtD
Benzphetamine—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.000269	0.00475	CcSEcCtD
Benzphetamine—Nausea—Miglitol—type 2 diabetes mellitus	0.000268	0.00473	CcSEcCtD
Benzphetamine—Tremor—Glimepiride—type 2 diabetes mellitus	0.000262	0.00463	CcSEcCtD
Benzphetamine—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.000261	0.00461	CcSEcCtD
Benzphetamine—Dyspepsia—Repaglinide—type 2 diabetes mellitus	0.00026	0.0046	CcSEcCtD
Benzphetamine—Agitation—Glimepiride—type 2 diabetes mellitus	0.000257	0.00454	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	0.000255	0.00451	CcSEcCtD
Benzphetamine—Sweating—Gliclazide—type 2 diabetes mellitus	0.000254	0.00449	CcSEcCtD
Benzphetamine—Headache—Tolbutamide—type 2 diabetes mellitus	0.000254	0.00448	CcSEcCtD
Benzphetamine—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.000252	0.00445	CcSEcCtD
Benzphetamine—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000252	0.00444	CcSEcCtD
Benzphetamine—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.00025	0.00441	CcSEcCtD
Benzphetamine—Palpitations—Glimepiride—type 2 diabetes mellitus	0.000247	0.00436	CcSEcCtD
Benzphetamine—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000244	0.00431	CcSEcCtD
Benzphetamine—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000244	0.00431	CcSEcCtD
Benzphetamine—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.000242	0.00428	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.000241	0.00426	CcSEcCtD
Benzphetamine—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000241	0.00425	CcSEcCtD
Benzphetamine—Hyperhidrosis—Glipizide—type 2 diabetes mellitus	0.000237	0.00418	CcSEcCtD
Benzphetamine—Urticaria—Repaglinide—type 2 diabetes mellitus	0.000235	0.00415	CcSEcCtD
Benzphetamine—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000234	0.00413	CcSEcCtD
Benzphetamine—Anorexia—Glipizide—type 2 diabetes mellitus	0.000233	0.00412	CcSEcCtD
Benzphetamine—Agitation—Bromocriptine—type 2 diabetes mellitus	0.000232	0.00409	CcSEcCtD
Benzphetamine—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000231	0.00408	CcSEcCtD
Benzphetamine—Headache—Tolazamide—type 2 diabetes mellitus	0.000231	0.00408	CcSEcCtD
Benzphetamine—POR—liver—type 2 diabetes mellitus	0.00023	0.0256	CbGeAlD
Benzphetamine—Headache—Linagliptin—type 2 diabetes mellitus	0.000229	0.00404	CcSEcCtD
Benzphetamine—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.000227	0.004	CcSEcCtD
Benzphetamine—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000226	0.00399	CcSEcCtD
Benzphetamine—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.000223	0.00393	CcSEcCtD
Benzphetamine—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.000222	0.00392	CcSEcCtD
Benzphetamine—Insomnia—Glipizide—type 2 diabetes mellitus	0.000221	0.00391	CcSEcCtD
Benzphetamine—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.000221	0.0039	CcSEcCtD
Benzphetamine—Bepridil—KCNQ1—type 2 diabetes mellitus	0.00022	0.114	CrCbGaD
Benzphetamine—SLC18A2—liver—type 2 diabetes mellitus	0.000219	0.0244	CbGeAlD
Benzphetamine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000219	0.00387	CcSEcCtD
Benzphetamine—Nausea—Tolazamide—type 2 diabetes mellitus	0.000219	0.00387	CcSEcCtD
Benzphetamine—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000218	0.00385	CcSEcCtD
Benzphetamine—Anorexia—Glimepiride—type 2 diabetes mellitus	0.000218	0.00384	CcSEcCtD
Benzphetamine—Tremor—Glyburide—type 2 diabetes mellitus	0.000216	0.00382	CcSEcCtD
Benzphetamine—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.000215	0.0038	CcSEcCtD
Benzphetamine—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000213	0.00376	CcSEcCtD
Benzphetamine—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000212	0.00374	CcSEcCtD
Benzphetamine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000211	0.0236	CbGeAlD
Benzphetamine—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000211	0.00373	CcSEcCtD
Benzphetamine—Nausea—Acarbose—type 2 diabetes mellitus	0.00021	0.00372	CcSEcCtD
Benzphetamine—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000207	0.00365	CcSEcCtD
Benzphetamine—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000206	0.00363	CcSEcCtD
Benzphetamine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000203	0.00358	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000202	0.00357	CcSEcCtD
Benzphetamine—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000202	0.00357	CcSEcCtD
Benzphetamine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000201	0.0224	CbGeAlD
Benzphetamine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000201	0.00355	CcSEcCtD
Benzphetamine—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000201	0.00355	CcSEcCtD
Benzphetamine—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.0002	0.00354	CcSEcCtD
Benzphetamine—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000198	0.0035	CcSEcCtD
Benzphetamine—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000198	0.00349	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000197	0.00348	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000197	0.00347	CcSEcCtD
Benzphetamine—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000196	0.00347	CcSEcCtD
Benzphetamine—Urticaria—Glipizide—type 2 diabetes mellitus	0.000194	0.00343	CcSEcCtD
Benzphetamine—Tremor—Gliclazide—type 2 diabetes mellitus	0.000194	0.00343	CcSEcCtD
Benzphetamine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000191	0.00338	CcSEcCtD
Benzphetamine—Agitation—Gliclazide—type 2 diabetes mellitus	0.00019	0.00336	CcSEcCtD
Benzphetamine—Sweating—Losartan—type 2 diabetes mellitus	0.000189	0.00333	CcSEcCtD
Benzphetamine—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000186	0.00329	CcSEcCtD
Benzphetamine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000186	0.00329	CcSEcCtD
Benzphetamine—Headache—Repaglinide—type 2 diabetes mellitus	0.000185	0.00327	CcSEcCtD
Benzphetamine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000185	0.00326	CcSEcCtD
Benzphetamine—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000183	0.00323	CcSEcCtD
Benzphetamine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000182	0.00321	CcSEcCtD
Benzphetamine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000181	0.0032	CcSEcCtD
Benzphetamine—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000181	0.0032	CcSEcCtD
Benzphetamine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000181	0.00319	CcSEcCtD
Benzphetamine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00018	0.00318	CcSEcCtD
Benzphetamine—Anorexia—Glyburide—type 2 diabetes mellitus	0.000179	0.00317	CcSEcCtD
Benzphetamine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000179	0.00316	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000178	0.00314	CcSEcCtD
Benzphetamine—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000177	0.0198	CbGeAlD
Benzphetamine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000177	0.0198	CbGeAlD
Benzphetamine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000176	0.0031	CcSEcCtD
Benzphetamine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000175	0.00309	CcSEcCtD
Benzphetamine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000173	0.00305	CcSEcCtD
Benzphetamine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000168	0.00297	CcSEcCtD
Benzphetamine—Palpitations—Valsartan—type 2 diabetes mellitus	0.000168	0.00297	CcSEcCtD
Benzphetamine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000168	0.00296	CcSEcCtD
Benzphetamine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000167	0.00296	CcSEcCtD
Benzphetamine—Palpitations—Orlistat—type 2 diabetes mellitus	0.000166	0.00293	CcSEcCtD
Benzphetamine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000166	0.00293	CcSEcCtD
Benzphetamine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000166	0.00293	CcSEcCtD
Benzphetamine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000165	0.00291	CcSEcCtD
Benzphetamine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000164	0.00289	CcSEcCtD
Benzphetamine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000164	0.00289	CcSEcCtD
Benzphetamine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000163	0.00289	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000163	0.00287	CcSEcCtD
Benzphetamine—Tremor—Metformin—type 2 diabetes mellitus	0.000162	0.00287	CcSEcCtD
Benzphetamine—Sweating—Ramipril—type 2 diabetes mellitus	0.000162	0.00286	CcSEcCtD
Benzphetamine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000162	0.00286	CcSEcCtD
Benzphetamine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00016	0.00283	CcSEcCtD
Benzphetamine—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000159	0.0178	CbGeAlD
Benzphetamine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000156	0.00276	CcSEcCtD
Benzphetamine—CYP2B6—kidney—type 2 diabetes mellitus	0.000156	0.0174	CbGeAlD
Benzphetamine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000156	0.00275	CcSEcCtD
Benzphetamine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000155	0.00274	CcSEcCtD
Benzphetamine—Headache—Glipizide—type 2 diabetes mellitus	0.000153	0.00271	CcSEcCtD
Benzphetamine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000153	0.00271	CcSEcCtD
Benzphetamine—Palpitations—Metformin—type 2 diabetes mellitus	0.000153	0.0027	CcSEcCtD
Benzphetamine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000153	0.0027	CcSEcCtD
Benzphetamine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000151	0.00267	CcSEcCtD
Benzphetamine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000151	0.00266	CcSEcCtD
Benzphetamine—Agitation—Irbesartan—type 2 diabetes mellitus	0.00015	0.00265	CcSEcCtD
Benzphetamine—Urticaria—Glyburide—type 2 diabetes mellitus	0.00015	0.00264	CcSEcCtD
Benzphetamine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000149	0.00263	CcSEcCtD
Benzphetamine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000149	0.0166	CbGeAlD
Benzphetamine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000148	0.00262	CcSEcCtD
Benzphetamine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000148	0.00261	CcSEcCtD
Benzphetamine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000147	0.00259	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000146	0.00258	CcSEcCtD
Benzphetamine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000146	0.0162	CbGeAlD
Benzphetamine—Nausea—Glipizide—type 2 diabetes mellitus	0.000145	0.00257	CcSEcCtD
Benzphetamine—Tremor—Losartan—type 2 diabetes mellitus	0.000144	0.00255	CcSEcCtD
Benzphetamine—Headache—Glimepiride—type 2 diabetes mellitus	0.000143	0.00253	CcSEcCtD
Benzphetamine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000143	0.00252	CcSEcCtD
Benzphetamine—Agitation—Losartan—type 2 diabetes mellitus	0.000141	0.0025	CcSEcCtD
Benzphetamine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000141	0.00249	CcSEcCtD
Benzphetamine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000141	0.00248	CcSEcCtD
Benzphetamine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000139	0.00245	CcSEcCtD
Benzphetamine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000139	0.00245	CcSEcCtD
Benzphetamine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000137	0.00241	CcSEcCtD
Benzphetamine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000137	0.00241	CcSEcCtD
Benzphetamine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000136	0.0024	CcSEcCtD
Benzphetamine—Palpitations—Losartan—type 2 diabetes mellitus	0.000136	0.0024	CcSEcCtD
Benzphetamine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000136	0.00239	CcSEcCtD
Benzphetamine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000135	0.00239	CcSEcCtD
Benzphetamine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000135	0.00239	CcSEcCtD
Benzphetamine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000135	0.00238	CcSEcCtD
Benzphetamine—Anorexia—Metformin—type 2 diabetes mellitus	0.000135	0.00238	CcSEcCtD
Benzphetamine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000135	0.015	CbGeAlD
Benzphetamine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000134	0.00237	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000134	0.00237	CcSEcCtD
Benzphetamine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000133	0.00236	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000133	0.00234	CcSEcCtD
Benzphetamine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00013	0.0023	CcSEcCtD
Benzphetamine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000129	0.00228	CcSEcCtD
Benzphetamine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000129	0.00228	CcSEcCtD
Benzphetamine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000129	0.00227	CcSEcCtD
Benzphetamine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000127	0.00225	CcSEcCtD
Benzphetamine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000125	0.0022	CcSEcCtD
Benzphetamine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000125	0.0022	CcSEcCtD
Benzphetamine—ADRA1A—liver—type 2 diabetes mellitus	0.000124	0.0139	CbGeAlD
Benzphetamine—Tremor—Ramipril—type 2 diabetes mellitus	0.000124	0.00218	CcSEcCtD
Benzphetamine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000123	0.00218	CcSEcCtD
Benzphetamine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000123	0.00217	CcSEcCtD
Benzphetamine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000123	0.00216	CcSEcCtD
Benzphetamine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000122	0.00216	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000122	0.00216	CcSEcCtD
Benzphetamine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000122	0.00215	CcSEcCtD
Benzphetamine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000121	0.00214	CcSEcCtD
Benzphetamine—Agitation—Ramipril—type 2 diabetes mellitus	0.000121	0.00214	CcSEcCtD
Benzphetamine—Anorexia—Losartan—type 2 diabetes mellitus	0.00012	0.00211	CcSEcCtD
Benzphetamine—Headache—Glyburide—type 2 diabetes mellitus	0.000118	0.00208	CcSEcCtD
Benzphetamine—CYP3A4—kidney—type 2 diabetes mellitus	0.000118	0.0131	CbGeAlD
Benzphetamine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000118	0.00207	CcSEcCtD
Benzphetamine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000117	0.00206	CcSEcCtD
Benzphetamine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000116	0.00205	CcSEcCtD
Benzphetamine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000116	0.00204	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000115	0.00203	CcSEcCtD
Benzphetamine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000114	0.00202	CcSEcCtD
Benzphetamine—Insomnia—Losartan—type 2 diabetes mellitus	0.000114	0.00201	CcSEcCtD
Benzphetamine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000113	0.002	CcSEcCtD
Benzphetamine—Urticaria—Metformin—type 2 diabetes mellitus	0.000112	0.00198	CcSEcCtD
Benzphetamine—Nausea—Glyburide—type 2 diabetes mellitus	0.000112	0.00197	CcSEcCtD
Benzphetamine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000112	0.00197	CcSEcCtD
Benzphetamine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000111	0.00195	CcSEcCtD
Benzphetamine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000109	0.00193	CcSEcCtD
Benzphetamine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000106	0.00188	CcSEcCtD
Benzphetamine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000106	0.00187	CcSEcCtD
Benzphetamine—Headache—Gliclazide—type 2 diabetes mellitus	0.000106	0.00187	CcSEcCtD
Benzphetamine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000105	0.00186	CcSEcCtD
Benzphetamine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000105	0.00185	CcSEcCtD
Benzphetamine—Bepridil—CALM1—type 2 diabetes mellitus	0.000105	0.0543	CrCbGaD
Benzphetamine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000104	0.00184	CcSEcCtD
Benzphetamine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000103	0.00181	CcSEcCtD
Benzphetamine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000103	0.00181	CcSEcCtD
Benzphetamine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000102	0.00179	CcSEcCtD
Benzphetamine—Nausea—Gliclazide—type 2 diabetes mellitus	0.0001	0.00177	CcSEcCtD
Benzphetamine—Urticaria—Losartan—type 2 diabetes mellitus	9.98e-05	0.00176	CcSEcCtD
Benzphetamine—CYP2B6—liver—type 2 diabetes mellitus	9.86e-05	0.011	CbGeAlD
Benzphetamine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	9.84e-05	0.00174	CcSEcCtD
Benzphetamine—Insomnia—Ramipril—type 2 diabetes mellitus	9.74e-05	0.00172	CcSEcCtD
Benzphetamine—Headache—Valsartan—type 2 diabetes mellitus	9.73e-05	0.00172	CcSEcCtD
Benzphetamine—Diarrhoea—Metformin—type 2 diabetes mellitus	9.68e-05	0.00171	CcSEcCtD
Benzphetamine—Headache—Orlistat—type 2 diabetes mellitus	9.62e-05	0.0017	CcSEcCtD
Benzphetamine—Dyspepsia—Ramipril—type 2 diabetes mellitus	9.48e-05	0.00167	CcSEcCtD
Benzphetamine—Decreased appetite—Ramipril—type 2 diabetes mellitus	9.36e-05	0.00165	CcSEcCtD
Benzphetamine—Dizziness—Metformin—type 2 diabetes mellitus	9.35e-05	0.00165	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	9.3e-05	0.00164	CcSEcCtD
Benzphetamine—Hypersensitivity—Losartan—type 2 diabetes mellitus	9.26e-05	0.00163	CcSEcCtD
Benzphetamine—Nausea—Valsartan—type 2 diabetes mellitus	9.23e-05	0.00163	CcSEcCtD
Benzphetamine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	9.13e-05	0.00161	CcSEcCtD
Benzphetamine—Nausea—Orlistat—type 2 diabetes mellitus	9.12e-05	0.00161	CcSEcCtD
Benzphetamine—Headache—Metformin—type 2 diabetes mellitus	8.86e-05	0.00156	CcSEcCtD
Benzphetamine—Dizziness—Irbesartan—type 2 diabetes mellitus	8.83e-05	0.00156	CcSEcCtD
Benzphetamine—Diarrhoea—Losartan—type 2 diabetes mellitus	8.6e-05	0.00152	CcSEcCtD
Benzphetamine—Urticaria—Ramipril—type 2 diabetes mellitus	8.56e-05	0.00151	CcSEcCtD
Benzphetamine—Nausea—Metformin—type 2 diabetes mellitus	8.4e-05	0.00148	CcSEcCtD
Benzphetamine—Headache—Irbesartan—type 2 diabetes mellitus	8.36e-05	0.00148	CcSEcCtD
Benzphetamine—Dizziness—Losartan—type 2 diabetes mellitus	8.31e-05	0.00147	CcSEcCtD
Benzphetamine—Phenoxybenzamine—CALM1—type 2 diabetes mellitus	8.16e-05	0.0423	CrCbGaD
Benzphetamine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.94e-05	0.0014	CcSEcCtD
Benzphetamine—Nausea—Irbesartan—type 2 diabetes mellitus	7.93e-05	0.0014	CcSEcCtD
Benzphetamine—Headache—Losartan—type 2 diabetes mellitus	7.87e-05	0.00139	CcSEcCtD
Benzphetamine—Nausea—Losartan—type 2 diabetes mellitus	7.46e-05	0.00132	CcSEcCtD
Benzphetamine—CYP3A4—liver—type 2 diabetes mellitus	7.44e-05	0.0083	CbGeAlD
Benzphetamine—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.37e-05	0.0013	CcSEcCtD
Benzphetamine—Dizziness—Ramipril—type 2 diabetes mellitus	7.12e-05	0.00126	CcSEcCtD
Benzphetamine—Headache—Ramipril—type 2 diabetes mellitus	6.75e-05	0.00119	CcSEcCtD
Benzphetamine—Promethazine—CALM1—type 2 diabetes mellitus	6.71e-05	0.0348	CrCbGaD
Benzphetamine—Nausea—Ramipril—type 2 diabetes mellitus	6.4e-05	0.00113	CcSEcCtD
Benzphetamine—Toremifene—CYP1A2—type 2 diabetes mellitus	5.24e-05	0.0272	CrCbGaD
Benzphetamine—Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	4.53e-05	0.0235	CrCbGaD
Benzphetamine—Phenytoin—ABCC2—type 2 diabetes mellitus	4.11e-05	0.0213	CrCbGaD
Benzphetamine—Methamphetamine—ADRA2A—type 2 diabetes mellitus	3.9e-05	0.0202	CrCbGaD
Benzphetamine—Oxaprozin—PTGS2—type 2 diabetes mellitus	3.88e-05	0.0201	CrCbGaD
Benzphetamine—Propafenone—CYP1A2—type 2 diabetes mellitus	3.69e-05	0.0192	CrCbGaD
Benzphetamine—Selegiline—CYP2E1—type 2 diabetes mellitus	3.69e-05	0.0191	CrCbGaD
Benzphetamine—Phenoxybenzamine—ADRA2A—type 2 diabetes mellitus	3.69e-05	0.0191	CrCbGaD
Benzphetamine—Atomoxetine—HTR2C—type 2 diabetes mellitus	3.53e-05	0.0183	CrCbGaD
Benzphetamine—Selegiline—CYP1A2—type 2 diabetes mellitus	3.51e-05	0.0182	CrCbGaD
Benzphetamine—Toremifene—CYP3A4—type 2 diabetes mellitus	3.47e-05	0.018	CrCbGaD
Benzphetamine—Alimemazine—CYP3A4—type 2 diabetes mellitus	3.26e-05	0.0169	CrCbGaD
Benzphetamine—Trimipramine—ADRA2A—type 2 diabetes mellitus	3.15e-05	0.0163	CrCbGaD
Benzphetamine—Tamoxifen—ABCC2—type 2 diabetes mellitus	3.14e-05	0.0163	CrCbGaD
Benzphetamine—Modafinil—CYP1A2—type 2 diabetes mellitus	3.1e-05	0.016	CrCbGaD
Benzphetamine—Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	3e-05	0.0156	CrCbGaD
Benzphetamine—Trimipramine—HTR2C—type 2 diabetes mellitus	2.9e-05	0.015	CrCbGaD
Benzphetamine—Phenprocoumon—CYP3A4—type 2 diabetes mellitus	2.82e-05	0.0146	CrCbGaD
Benzphetamine—Promazine—ADRA2A—type 2 diabetes mellitus	2.67e-05	0.0138	CrCbGaD
Benzphetamine—Phenylbutazone—CYP3A4—type 2 diabetes mellitus	2.62e-05	0.0136	CrCbGaD
Benzphetamine—Phenylbutazone—PTGS2—type 2 diabetes mellitus	2.56e-05	0.0133	CrCbGaD
Benzphetamine—Phenprocoumon—ALB—type 2 diabetes mellitus	2.46e-05	0.0128	CrCbGaD
Benzphetamine—Promazine—HTR2C—type 2 diabetes mellitus	2.46e-05	0.0127	CrCbGaD
Benzphetamine—Propafenone—CYP3A4—type 2 diabetes mellitus	2.45e-05	0.0127	CrCbGaD
Benzphetamine—Levomethadyl Acetate—CYP3A4—type 2 diabetes mellitus	2.34e-05	0.0122	CrCbGaD
Benzphetamine—Selegiline—CYP3A4—type 2 diabetes mellitus	2.33e-05	0.0121	CrCbGaD
Benzphetamine—Tamoxifen—CYP2E1—type 2 diabetes mellitus	2.2e-05	0.0114	CrCbGaD
Benzphetamine—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	2.15e-05	0.0111	CrCbGaD
Benzphetamine—Orphenadrine—CYP2E1—type 2 diabetes mellitus	2.14e-05	0.0111	CrCbGaD
Benzphetamine—Tamoxifen—CYP1A2—type 2 diabetes mellitus	2.09e-05	0.0109	CrCbGaD
Benzphetamine—Methadone—CYP1A2—type 2 diabetes mellitus	2.08e-05	0.0108	CrCbGaD
Benzphetamine—Modafinil—CYP3A4—type 2 diabetes mellitus	2.05e-05	0.0106	CrCbGaD
Benzphetamine—Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	2.03e-05	0.0105	CrCbGaD
Benzphetamine—Fentanyl—CYP3A4—type 2 diabetes mellitus	2e-05	0.0104	CrCbGaD
Benzphetamine—Promazine—CYP1A2—type 2 diabetes mellitus	1.86e-05	0.00962	CrCbGaD
Benzphetamine—Phenytoin—CYP3A4—type 2 diabetes mellitus	1.82e-05	0.00942	CrCbGaD
Benzphetamine—Atomoxetine—CYP3A4—type 2 diabetes mellitus	1.76e-05	0.00914	CrCbGaD
Benzphetamine—Phenoxybenzamine—CYP3A4—type 2 diabetes mellitus	1.7e-05	0.0088	CrCbGaD
Benzphetamine—Phenytoin—ALB—type 2 diabetes mellitus	1.59e-05	0.00822	CrCbGaD
Benzphetamine—Trimipramine—CYP3A4—type 2 diabetes mellitus	1.45e-05	0.00752	CrCbGaD
Benzphetamine—Tamoxifen—CYP3A4—type 2 diabetes mellitus	1.39e-05	0.00719	CrCbGaD
Benzphetamine—Methadone—CYP3A4—type 2 diabetes mellitus	1.37e-05	0.00713	CrCbGaD
Benzphetamine—Orphenadrine—CYP3A4—type 2 diabetes mellitus	1.35e-05	0.00698	CrCbGaD
Benzphetamine—Promazine—CYP3A4—type 2 diabetes mellitus	1.23e-05	0.00637	CrCbGaD
Benzphetamine—ADRA2A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.75e-06	0.000111	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP2E1—type 2 diabetes mellitus	3.73e-06	0.00011	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	3.73e-06	0.00011	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	3.72e-06	0.00011	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	3.72e-06	0.00011	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	3.7e-06	0.000109	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	3.7e-06	0.000109	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP1A2—type 2 diabetes mellitus	3.69e-06	0.000109	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SLC2A1—type 2 diabetes mellitus	3.69e-06	0.000109	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	3.67e-06	0.000108	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	3.65e-06	0.000108	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	3.64e-06	0.000107	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	3.64e-06	0.000107	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	3.6e-06	0.000106	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.6e-06	0.000106	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AGT—type 2 diabetes mellitus	3.59e-06	0.000106	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	3.57e-06	0.000105	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	3.54e-06	0.000104	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GCG—type 2 diabetes mellitus	3.54e-06	0.000104	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.54e-06	0.000104	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	3.53e-06	0.000104	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CYBA—type 2 diabetes mellitus	3.53e-06	0.000104	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.46e-06	0.000102	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PLAT—type 2 diabetes mellitus	3.45e-06	0.000102	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GHRL—type 2 diabetes mellitus	3.45e-06	0.000102	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.44e-06	0.000101	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	3.44e-06	0.000101	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	3.44e-06	0.000101	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	3.44e-06	0.000101	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CALCA—type 2 diabetes mellitus	3.41e-06	0.000101	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.4e-06	0.0001	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GCG—type 2 diabetes mellitus	3.4e-06	0.0001	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—SRC—type 2 diabetes mellitus	3.39e-06	0.0001	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.34e-06	9.85e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.33e-06	9.82e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	3.32e-06	9.77e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—VEGFA—type 2 diabetes mellitus	3.31e-06	9.75e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	3.29e-06	9.71e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	3.29e-06	9.71e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GNB3—type 2 diabetes mellitus	3.25e-06	9.59e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.25e-06	9.59e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—HMOX1—type 2 diabetes mellitus	3.24e-06	9.55e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.21e-06	9.47e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.2e-06	9.42e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CAT—type 2 diabetes mellitus	3.2e-06	9.42e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.18e-06	9.37e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	3.17e-06	9.35e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	3.17e-06	9.35e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.16e-06	9.31e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GCG—type 2 diabetes mellitus	3.16e-06	9.31e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.12e-06	9.21e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.12e-06	9.2e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	3.11e-06	9.18e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.11e-06	9.16e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—APOB—type 2 diabetes mellitus	3.1e-06	9.15e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.1e-06	9.13e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	3.06e-06	9.03e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	3.06e-06	9.03e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	3.06e-06	9.03e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.05e-06	8.99e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GNB3—type 2 diabetes mellitus	3.05e-06	8.99e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—HMOX1—type 2 diabetes mellitus	3.04e-06	8.95e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TGFB1—type 2 diabetes mellitus	3.03e-06	8.94e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GSTM1—type 2 diabetes mellitus	3.02e-06	8.9e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CAT—type 2 diabetes mellitus	3e-06	8.83e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—LPL—type 2 diabetes mellitus	2.96e-06	8.73e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.96e-06	8.71e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.95e-06	8.71e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.93e-06	8.63e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	2.91e-06	8.58e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.9e-06	8.56e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ADCY5—type 2 diabetes mellitus	2.9e-06	8.55e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.9e-06	8.55e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GPX1—type 2 diabetes mellitus	2.89e-06	8.52e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AVP—type 2 diabetes mellitus	2.89e-06	8.52e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.89e-06	8.52e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	2.88e-06	8.49e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.88e-06	8.48e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.86e-06	8.44e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.83e-06	8.35e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	2.83e-06	8.34e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CD36—type 2 diabetes mellitus	2.82e-06	8.3e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APOB—type 2 diabetes mellitus	2.79e-06	8.23e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.78e-06	8.2e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PPP2CA—type 2 diabetes mellitus	2.78e-06	8.19e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	2.78e-06	8.19e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.75e-06	8.1e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.75e-06	8.1e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.72e-06	8.02e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	2.72e-06	8.02e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	2.71e-06	7.99e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	2.7e-06	7.95e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.68e-06	7.91e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AVP—type 2 diabetes mellitus	2.68e-06	7.91e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.67e-06	7.88e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—MTHFR—type 2 diabetes mellitus	2.67e-06	7.86e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LPL—type 2 diabetes mellitus	2.67e-06	7.86e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.66e-06	7.84e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	2.64e-06	7.78e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.63e-06	7.76e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PPARA—type 2 diabetes mellitus	2.62e-06	7.71e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.61e-06	7.69e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.61e-06	7.68e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	2.6e-06	7.67e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	2.6e-06	7.67e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	2.6e-06	7.67e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	2.6e-06	7.67e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APOB—type 2 diabetes mellitus	2.59e-06	7.65e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.58e-06	7.62e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.55e-06	7.53e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—AGT—type 2 diabetes mellitus	2.53e-06	7.47e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.5e-06	7.37e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	2.5e-06	7.37e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.5e-06	7.36e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CALM1—type 2 diabetes mellitus	2.49e-06	7.35e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—APOE—type 2 diabetes mellitus	2.48e-06	7.32e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LPL—type 2 diabetes mellitus	2.48e-06	7.3e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.46e-06	7.24e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—APOA1—type 2 diabetes mellitus	2.46e-06	7.24e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	2.45e-06	7.23e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.43e-06	7.15e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—C3—type 2 diabetes mellitus	2.4e-06	7.08e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	2.38e-06	7e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	2.34e-06	6.89e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	2.33e-06	6.86e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.32e-06	6.85e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.32e-06	6.84e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	2.3e-06	6.78e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.29e-06	6.75e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.28e-06	6.73e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.28e-06	6.73e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	2.28e-06	6.72e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.24e-06	6.61e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	2.24e-06	6.59e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	2.24e-06	6.59e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—C3—type 2 diabetes mellitus	2.23e-06	6.57e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.21e-06	6.51e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.17e-06	6.39e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PPARG—type 2 diabetes mellitus	2.16e-06	6.38e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.13e-06	6.27e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.12e-06	6.26e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.12e-06	6.26e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.12e-06	6.25e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	2.12e-06	6.25e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	2.12e-06	6.25e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	2.11e-06	6.22e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.11e-06	6.21e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.08e-06	6.14e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.08e-06	6.14e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	2.08e-06	6.12e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	2.08e-06	6.12e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.07e-06	6.1e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.07e-06	6.1e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.07e-06	6.1e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.06e-06	6.06e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.05e-06	6.05e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	2.03e-06	5.98e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.02e-06	5.95e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2e-06	5.88e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.99e-06	5.88e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	1.99e-06	5.86e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.96e-06	5.77e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	1.95e-06	5.73e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	1.91e-06	5.63e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.88e-06	5.54e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.86e-06	5.48e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	1.86e-06	5.48e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.86e-06	5.47e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.86e-06	5.47e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.86e-06	5.47e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.85e-06	5.46e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.85e-06	5.44e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.85e-06	5.44e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.84e-06	5.42e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	1.82e-06	5.38e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.82e-06	5.37e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.8e-06	5.32e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.77e-06	5.23e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.77e-06	5.21e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.75e-06	5.17e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.75e-06	5.15e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.74e-06	5.14e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	1.74e-06	5.14e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.72e-06	5.06e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.71e-06	5.05e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.71e-06	5.03e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.7e-06	5.02e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.7e-06	5e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.68e-06	4.95e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.68e-06	4.95e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.67e-06	4.94e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.67e-06	4.94e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.63e-06	4.8e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.61e-06	4.74e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.61e-06	4.74e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	1.6e-06	4.7e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.58e-06	4.65e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.56e-06	4.59e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.56e-06	4.59e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.46e-06	4.32e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.43e-06	4.23e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.42e-06	4.19e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.41e-06	4.16e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.39e-06	4.09e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.39e-06	4.09e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.38e-06	4.07e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.36e-06	4.01e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.34e-06	3.96e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.33e-06	3.93e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.33e-06	3.92e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.32e-06	3.9e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.32e-06	3.89e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.31e-06	3.87e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.3e-06	3.84e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.29e-06	3.79e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.26e-06	3.72e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.25e-06	3.68e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.24e-06	3.65e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.24e-06	3.64e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.23e-06	3.64e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.23e-06	3.63e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.21e-06	3.57e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.21e-06	3.56e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.2e-06	3.54e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.18e-06	3.49e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.15e-06	3.39e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.14e-06	3.35e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.12e-06	3.3e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.12e-06	3.29e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.11e-06	3.26e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.09e-06	3.2e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.08e-06	3.18e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.06e-06	3.13e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.06e-06	3.12e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.05e-06	3.08e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.03e-06	3.03e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.01e-06	2.97e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	9.22e-07	2.72e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	9.04e-07	2.66e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	8.55e-07	2.52e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	8.34e-07	2.46e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	8.29e-07	2.44e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	8.02e-07	2.36e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	7.93e-07	2.34e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	7.93e-07	2.34e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.75e-07	2.28e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.7e-07	2.27e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	7.25e-07	2.14e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.15e-07	2.11e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.64e-07	1.07e-05	CbGpPWpGaD
